11:56 AM EST - Angiotech Pharmaceuticals, Inc. : reported third-quarter net loss of $7.8 million U.S. or $0.09 U.S. per share, compared to net loss of $622.38 million U.S. or $7.31 U.S. per share last year. The company noted that the prior-year results were restated. Adjusted net income was $100,000 U.S. or breakeven per share. Revenue declined to $63.24 million U.S. from $68.36 million U.S. in the same quarter last year. Angiotech Pharmaceuticals, Inc.
shares T.ANP are trading down $0.03 at $1.46.
